News from Frostrow Capital
Close Investments loses three trusts to former MD
by Nyree Stewart, 10 Apr 2007
Frostrow Capital, a company set up by four former members of the investment
trust team at Close Investments, has already taken over three mandates from
Close within a day of being launched.
Headed up by Alastair Smith, the former managing director of Close Finsbury
Asset Management, Frostrow Capital is majority owned by its executive team which
includes Grant Challis, Mark Pope and Tracy Arthur, all former employees of
Close Investments, a subsidiary of Close Brothers Group.
The company, as an independent boutique provider of management services to
investment companies, claims it is unique in being “exclusively dedicated to
performing the entire executive function for investment companies”, with the
exception of portfolio management.
As a result, it aims to win mandates from investment companies where the
boards prefer to separate the company management and investment management
functions, although it points out as it has “access to the investment industry’s
leading advisers and investors”, it will also be actively seeking to launch new
investment companies.
However, it has confirmed it has already been appointed as manager of three
listed investment trusts, previously managed by former employer Close
Investments, with immediate effect.
The mandates - Finsbury Growth & Income Trust, Finsbury Emerging
Biotechnology Trust, and Finsbury Worldwide Pharmaceutical Trust - are worth
approximately £494m in total, on a market capitalisation basis, although all
three investment trusts will retain their existing investment managers.
This means Lindsell Train Investment Management will continue for Finsbury
Growth & Income Trust, while OrbiMed Advisers will stay in place for Finsbury
Emerging Biotechnology Trust and Finsbury Worldwide Pharmaceutical Trust.
In addition, the company says it is “actively working” with Close Investments
to achieve an efficient and successful handover of responsibilities.
Challis, partner for business development at Frostrow Capital, says the firm
believes there is a real need for a boutique approach to managing investment
companies.
He says: “Currently, for virtually all investment companies, this function is
either performed by specialist fund managers who would rather be spending their
time picking stocks or it is a non-core activity within large investment houses.
“In neither case are shareholder interests likely to be as well served as
they could be by an independent specialist such as Frostrow Capital.”
And Smith, managing partner at the firm, says: “We have assembled an
excellent team of proven investment company specialists and are all very excited
to be launching our new enterprise.”